Roche's shares Monday fell nearly 5 percent after Genentech, its South San Francisco subsidiary, said a once-promising drug combination to treat lung cancer failed to block tumor growth.
http://ift.tt/1i0FJlg
http://ift.tt/1i0FJlg
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment